Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-02-03FDA Approved: VIZAMYL — Supplemental Application (GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare))
FDA approved a supplemental application for Vizamyl (flutemetamol F-18) from GE Healthcare, indicating regulatory approval of a supplemental…
-
CLINICAL_TRIALS trial_result · 2015-02-03Clinical Trial Update: Multi-modality MRI Study on Prediction for Mild Cognitive Impairment Conversion
A completed clinical trial study evaluating multi-modality MRI data to predict conversion from mild cognitive impairment to Alzheimer's dise…
-
CLINICAL_TRIALS research · 2015-01-30Clinical Trial Update: Patients With Alzheimer Disease, Spouse Carers and Risk of Institutionalization: a Prospective Observational Cohort Study of Dyads (AID Study)
A prospective observational cohort study (AID Study) examines how Alzheimer’s disease in patients and the involvement of spouse caregivers r…
-
FDA approval · 2015-01-30FDA Approved: DONEPEZIL — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved the original application for donepezil hydrochloride (generic) by Quallent Pharmaceuticals Health LLC, extending its availabili…
-
CLINICAL_TRIALS trial_result · 2015-01-27Clinical Trial Update: Safety, Efficacy and Dose Titration of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update on the safety, efficacy, and dose titration of Sodium Oligo-mannurarate capsules in mild-to-moderate Alzheimer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: A Two-Part, Single-Dose Study of the Pharmacokinetics of MK-8931 in Subjects With Renal Insufficiency (MK-8931-009 [P08535]) [Phase 1]
This Phase 1 pharmacokinetic study evaluated MK-8931 (verubecestat) in subjects with renal impairment after a single-dose administration to …
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease [NA]
The document reports that the efficacy study of the ZT-1 implant in patients with moderate Alzheimer's disease has completed. No results are…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy Volunteers [Phase 1]
Phase 1 clinical trial update evaluating ZK 6032924 in probable Alzheimer's disease patients vs. healthy volunteers, with radiation dosimetr…
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: LIWA for Treatment of Alzheimer Patients [Phase 1, Phase 2]
This document reports a Phase 1/Phase 2 clinical trial evaluating LIWA for Alzheimer's disease, with the current trial status listed as unkn…
-
CLINICAL_TRIALS trial_result · 2015-01-05Clinical Trial Update: Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 amyloid imaging and safety study of ACC-001 in subjects with mild to moderate Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Telephone Resources and Assistance for Caregivers (TRAC) [NA]
This update notes that the TRAC study, which evaluated telephone resources and assistance for caregivers of individuals with Alzheimer's dis…
-
FDA approval · 2014-12-23FDA Approved: NAMZARIC — Original Application (Allergan, Inc.)
FDA approved NAMZARIC, a fixed-dose combination of memantine hydrochloride and donepezil hydrochloride, under an original application from A…
-
CLINICAL_TRIALS trial_result · 2014-12-22Clinical Trial Update: Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease [Phase 2]
A Phase 2 long-term extension study of ACC-001 in Japanese subjects with mild-to-moderate Alzheimer's disease was terminated; results relate…
-
CLINICAL_TRIALS other · 2014-12-12Clinical Trial Update: Collaboration Between Department of Old Age Psychiatry and Nursing Homes [NA]
A completed clinical trial update describing a collaboration between the Department of Old Age Psychiatry and nursing homes, with dementia a…
-
FDA approval · 2014-12-04FDA Approved: VIZAMYL — Supplemental Application (GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare))
The FDA approved a supplemental application for Vizamyl (flutemetamol F-18) by GE Healthcare.
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Physical Exercise as an Additional Treatment for Alzheimer Disease [NA]
A completed clinical trial evaluated physical exercise as an additional treatment for Alzheimer's disease. The study was sponsored by Univer…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Effect of Physical Exercise in Alzheimer Patients [Phase 3]
A Phase 3 clinical trial assessing the effect of physical exercise on patients with Alzheimer disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: Home Evaluation of Exit Barriers in Wandering [NA]
A completed clinical trial evaluated home exit barriers to manage wandering in individuals with Alzheimer's-type dementia; results were post…
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]
A Phase 2 clinical trial update assessing the efficacy and safety of ABT-126 in individuals with mild to moderate Alzheimer's disease has co…
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: 3-month Study of MSDC-0160 Effects on Brain Glucose Utilization, Cognition & Safety in Subjects With Alzheimer's Disease [Phase 2]
Phase 2 trial evaluating MSDC-0160 on brain glucose utilization, cognition, and safety in Alzheimer's disease completed with results posted …
-
CLINICAL_TRIALS trial_result · 2014-10-31Clinical Trial Update: Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors [Phase 2]
This entry reports the completion of a Phase 2 clinical trial evaluating ABT-126 for mild to moderate Alzheimer's disease in patients taking…
-
CLINICAL_TRIALS trial_result · 2014-10-30Clinical Trial Update: Modafinil Treatment for Sleep/Wake Disturbances in Older Adults [Phase 4]
Phase 4 trial evaluating modafinil for sleep/wake disturbances in older adults; terminated with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Effects of Sage on Memory and Mental Performance in Alzheimer's Disease Patients [Phase 1]
A Phase 1 trial evaluating Sage (Salvia officinalis) for memory and mental performance in Alzheimer's disease patients has completed.
-
FDA approval · 2014-10-29FDA Approved: DONEPEZIL HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories, LLC)
The FDA approved Upsher-Smith Laboratories' generic donepezil hydrochloride product through an original application. The product is intended…
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Meditation or Education for Alzheimer Caregivers [Phase 2]
Phase 2 study evaluating meditation or education for caregivers of people with Alzheimer's disease; the trial status is completed.